These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31897471)

  • 1. An Insight into Gabapentin and Pregabalin in Scottish Prisoners.
    Deeb S; Wylie FM; Torrance HJ; Scott KS
    J Anal Toxicol; 2020 Apr; 44(5):504-513. PubMed ID: 31897471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles of pregabalin and gabapentin abuse by postmortem toxicology.
    Häkkinen M; Vuori E; Kalso E; Gergov M; Ojanperä I
    Forensic Sci Int; 2014 Aug; 241():1-6. PubMed ID: 24835028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid quantification of gabapentin, pregabalin, and vigabatrin in human serum by ultraperformance liquid chromatography with mass-spectrometric detection.
    Chahbouni A; Sinjewel A; den Burger JC; Vos RM; Wilhelm AJ; Veldkamp AI; Swart EL
    Ther Drug Monit; 2013 Feb; 35(1):48-53. PubMed ID: 23188183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of gabapentin, pregabalin, vigabatrin, and topiramate in plasma by HPLC with fluorescence detection.
    Martinc B; Roškar R; Grabnar I; Vovk T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():82-88. PubMed ID: 24907547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug screening in an Austrian prison].
    Lapornik R; Lehofer M; Rous F; Klampfer H; Hofmann P; Zapotoczky HG
    Nervenarzt; 1994 Sep; 65(9):633-4. PubMed ID: 7991011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin concentrations in post-mortem blood-A two year study.
    Eastwood JA; Davison E
    Forensic Sci Int; 2016 Sep; 266():197-201. PubMed ID: 27295075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated Method for the Screening and Quantification of Baclofen, Gabapentin and Pregabalin in Human Post-Mortem Whole Blood Using Protein Precipitation and Liquid Chromatography-Tandem Mass Spectrometry.
    Nahar L; Smith A; Patel R; Andrews R; Paterson S
    J Anal Toxicol; 2017 Jun; 41(5):441-450. PubMed ID: 28335036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misuse and Mortality Related to Gabapentin and Pregabalin are Being Under-Estimated: A Two-Year Post-Mortem Population Study.
    Nahar LK; Murphy KG; Paterson S
    J Anal Toxicol; 2019 Aug; 43(7):564-570. PubMed ID: 31062862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Random mandatory drugs testing of prisoners: a biassed means of gathering information.
    Gore SM; Bird AG; Strang JS
    J Epidemiol Biostat; 1999; 4(1):3-9. PubMed ID: 10613711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases.
    Deeb S; McKeown DA; Torrance HJ; Wylie FM; Logan BK; Scott KS
    J Anal Toxicol; 2014 Oct; 38(8):485-94. PubMed ID: 25217536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost implications of random mandatory drugs tests in prisons.
    Gore SM; Bird AG
    Lancet; 1996 Oct; 348(9035):1124-7. PubMed ID: 8888165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of drug abuse in prisoners in a major correctional institution.
    Sobota JT; Lummis L
    Clin Toxicol; 1974; 7(5):531-9. PubMed ID: 4442249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use in remand prisoners: a consecutive case study.
    Mason D; Birmingham L; Grubin D
    BMJ; 1997 Jul; 315(7099):18-21. PubMed ID: 9233320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
    Heikman P; Sundström M; Pelander A; Ojanperä I
    Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations.
    Patsalos PN; Zugman M; Lake C; James A; Ratnaraj N; Sander JW
    Epilepsia; 2017 Jul; 58(7):1234-1243. PubMed ID: 28542801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Concurrent Measurement of Gabapentin, Lamotrigine, Levetiracetam, Monohydroxy Derivative of Oxcarbazepine, and Zonisamide Concentrations in Serum in a Clinical Setting.
    Palte MJ; Basu SS; Dahlin JL; Gencheva R; Mason D; Jarolim P; Petrides AK
    Ther Drug Monit; 2018 Aug; 40(4):469-476. PubMed ID: 29994986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
    Androsova G; Krause R; Borghei M; Wassenaar M; Auce P; Avbersek A; Becker F; Berghuis B; Campbell E; Coppola A; Francis B; Wolking S; Cavalleri GL; Craig J; Delanty N; Koeleman BPC; Kunz WS; Lerche H; Marson AG; Sander JW; Sills GJ; Striano P; Zara F; Sisodiya SM; Depondt C;
    Epilepsia; 2017 Oct; 58(10):1734-1741. PubMed ID: 28857179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.